Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1

Keisuke Tanaka a, Yuuya Kasahara *ab, Yoichi Miyamoto b, Takumi Okuda a, Tatsuro Kasai c, Kentaro Onodera c, Masayasu Kuwahara cd, Masahiro Oka b, Yoshihiro Yoneda b and Satoshi Obika ab
aGraduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan
bNational Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan. E-mail: y-kasahara@nibiohn.go.jp
cGraduate School of Science and Technology, Gunma University, Gunma 376-8515, Japan
dGraduate School of Integrated Basic Sciences, Nihon University, Tokyo 156-8550, Japan

Received 25th September 2018 , Accepted 25th September 2018

First published on 4th October 2018


Correction for ‘Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1′ by Keisuke Tanaka et al., Org. Biomol. Chem., 2018, 16, 4456–4463.


The authors regret that one of the author's names, Takumi Okuda, was given incorrectly. The corrected list of authors is as shown above.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2018